PATRICIA KENNEDY: Open Payments
NPI 1124351325 · COOPERSTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,858 in 137 payments from 16 companies in 2025. Trend: 2023 $2,850 · 2024 $3,092 · 2025 $3,858
Food & beverage: $3,858
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $871 |
| ABBVIE INC. | 23 | $616 |
| Janssen Biotech, Inc. | 20 | $360 |
| Novartis Pharmaceuticals Corporation | 8 | $278 |
| Arcutis Biotherapeutics, Inc. | 14 | $245 |
| GENZYME CORPORATION | 8 | $194 |
| Lilly USA, LLC | 10 | $189 |
| Incyte Corporation | 10 | $188 |
| LEO Pharma Inc. | 9 | $185 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $184 |
Products named: NEMLUVIO, TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, Zoryve, OPZELURA, TALTZ.
Industry payments across NY — which companies pay providers there.
